Komori
Eisai (4523) · InitiativeFirst statedLatest Financial results presentation (2026-08-03): "Advanced"

Development of E2086 for the Treatment of Narcolepsy

First written in FY2026. 6 of 9 entries say "Advanced", first in 2026-05-15. Latest entry: 2026-08-03.

9entries
1years
8from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvanced2026-05-25First statedFY2026Advanced2026-07-14 – 2026-08-032026: 92026
Same theme, other companies
Clinical development of E2086 for narcolepsyA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  2. FY2026First statedAnnual report

    「不眠症治療剤「デエビゴ」の開発を通じて獲得した独自のオレキシンプラットフォームを活用し、創製したオレキシン2受容体アゴニスト「E2086」は、ナルコレプシータイプ1を対象としたフェーズⅠb試験において、患者様の日中の覚醒度を改善する可能性を示唆するデータを示し、現在、フェーズⅡ試験を実施中です。」

    デエビゴで得たオレキシンプラットフォームを活用し、E2086についてナルコレプシータイプ1対象のフェーズⅠb試験を経てフェーズⅡ試験を実施中と記載した。
Moved together

"Dementia Prevention and Treatment and Addressing Related Needs" moved the same way as this thread, in the same document, in 5 of its 9 moves.

5322★1234
  1. ★This thread
  2. 1Dementia Prevention and Treatment and Addressing Related Needs5×
  3. 2Creating new medicines aimed at curing cancer3×
  4. 3Phase III trial of the orexin receptor antagonist E2006 for insomnia2×
  5. 4Disease Continuum Analysis and Continuous Brain Health Panel Diagnostics2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Eisai yet. It last moved in the Financial results presentation of 2026-08-03: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Development of E2086 for the Treatment of Narcolepsy | Eisai Co.,Ltd. (4523) | Komori